Video

Custom ViewPoints Video Program

Treatment-Resistant Depression: Financial Support for Esketamine Therapy

Author(s):

Steven P. Levine, MD,Angelos Halaris, MD, PhD, APA, ACNP, CINP

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Recommendations that can help clinicians navigate through the reimbursement process and best support patients who receive intranasal esketamine for treatment-resistant depression.

      Related Videos
      Integrated Care and Treatment-Resistant Depression
      Integrated Care and Treatment-Resistant Depression
      Electroconvulsive Therapy for Depression
      Electroconvulsive Therapy for Depression
      Traditional Classes of Antidepressant Therapies
      Traditional Classes of Antidepressant Therapies
      Frontline Psychotherapy for Depression
      Frontline Psychotherapy for Depression
      Incorporating Esketamine into Practice for Treatment-Resistant Depression
      Incorporating Esketamine into Practice for Treatment-Resistant Depression
      Getting Certified to Administer Esketamine for Treatment-Resistant Depression
      Getting Certified to Administer Esketamine for Treatment-Resistant Depression
      Treatment-Resistant Depression: Administering Esketamine to Patients
      Treatment-Resistant Depression: Administering Esketamine to Patients
      REMS Safety Program for Esketamine in Treatment-Resistant Depression
      REMS Safety Program for Esketamine in Treatment-Resistant Depression
      Response to Esketamine Therapy for Treatment-Resistant Depression
      Response to Esketamine Therapy for Treatment-Resistant Depression
      Monitoring Patients on Esketamine Therapy for Treatment-Resistant Depression
      Monitoring Patients on Esketamine Therapy for Treatment-Resistant Depression
      Related Content
      © 2025 MJH Life Sciences

      All rights reserved.